China Healthwise Holdings (HKSE:00348) Total Operating Expense: HK$49.86 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is China Healthwise Holdings Total Operating Expense?

China Healthwise Holdings HKSE:00348 -6.12% Total Operating Expense is HK$49.86 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

China Healthwise Holdings's Total Operating Expense for the six months ended in Dec. 2025 was HK$27.94 Mil. China Healthwise Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$49.86 Mil.

China Healthwise Holdings Total Operating Expense Related Terms

China Healthwise Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for China Healthwise Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Healthwise Holdings Total Operating Expense Chart

China Healthwise Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.17 66.19 65.40 55.45 49.86

China Healthwise Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.22 32.85 22.60 21.93 27.94

China Healthwise Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$49.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of HK$49.86 Mil mean?
China Healthwise Holdings (HKSE:00348) has a Total Operating Expense of HK$49.86 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on China Healthwise Holdings and its competitors.
Is China Healthwise Holdings' Total Operating Expense too high?
China Healthwise Holdings' current Total Operating Expense is HK$49.86 Mil.
How does China Healthwise Holdings' Total Operating Expense compare to competitors?
China Healthwise Holdings' Total Operating Expense of HK$49.86 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on China Healthwise Holdings and its competitors. China Healthwise Holdings's current Total Operating Expense is HK$49.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.09 — trading 53.3% above its estimated fair value. The current Total Operating Expense is HK$49.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current Total Operating Expense is HK$49.86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China Healthwise Holdings Business Description

Address 168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.